Delivery Order SPE2DB22D1052-SPE2DB25FU7WH
Award Date
10/27/24
Potential Completion Date
10/28/24
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,570.20 firm fixed-price delivery order is for the BYDUREON BCISE 2 MG AUTOINJECT 0.85ML product, with a completion date of May 31, 2024. This award is a part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $24,325.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award, valued at $8,565.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a specialty medication. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, valued at $3,133.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the procurement of 4562967196 units of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a specialty medication. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award is a delivery order valued at $1,069.48, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a medication. It has an ultimate completion date of October 9, 2024 and is a firm fixed-price contract. AmerisourceBergen holds several large Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
This federal contract award, valued at $3,457.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a specialty medication. This contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,696.04, is for the delivery of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a medical product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of December 24, 2024. This award does not have a set-aside designation. AmerisourceBergen holds a $999,999,999...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $39,663.06 firm fixed-price delivery order is for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML medication. The contract has an ultimate completion date of May 12, 2023. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $2,969.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, with a completion date of November 16, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, valued at $8,996.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566593506 units of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a pharmaceutical product, with a completion date of December 4, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and does not have a set-aside designation. AmerisourceBergen...